Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 12

TABLE OF CONTENTS Volume 47, Issue 12 (December 2012) In this issue Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement If you are unable to access the articles in this Table of Contents e-alert in full, your library may not subscribe to this journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.   Reviews Top Allogeneic cellular and autologous stem cell therapy for sickle cell disease: ‘whom, when and how’ J Freed, J Talano, T Small, A Ricci and M S Cairo Bone Marrow Transplant 2012 47: 1489-1498; advance online publication, December 19, 2011; 10.1038/bmt.2011.245 Abstract | Full Text The role of HLA antibodies in allogeneic SCT: is the ‘type-and-screen’ strategy necessary not only for blood type but also for HLA? S Yoshihara, K Taniguchi, H Ogawa and H Saji Bone Marrow Transplant 2012 47: 1499-1506; advance online publication, January 9, 2012; 10.1038/bmt.2011.249 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia L P Xu, K Y Liu, D H Liu, W Han, H Chen, Y H Chen, X H Zhang, Y Wang, F R Wang, J Z Wang and X J Huang Bone Marrow Transplant 2012 47: 1507-1512; advance online publication, May 28, 2012; 10.1038/bmt.2012.79 Abstract | Full Text Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients D A Portier, R T Sabo, C H Roberts, D S Fletcher, J Meier, W B Clark, M C Neale, M H Manjili, J M McCarty, H M Chung and A A Toor Bone Marrow Transplant 2012 47: 1513-1519; advance online publication, May 14, 2012; 10.1038/bmt.2012.81 Abstract | Full Text STEM CELL PROCUREMENT Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years W E Janssen, D Rahn, M Hackett, D Coyle, M Tomblyn, R C Smilee, C Anasetti and H F Fernandez Bone Marrow Transplant 2012 47: 1520-1525; advance online publication, May 7, 2012; 10.1038/bmt.2012.65 Abstract | Full Text Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization A I Chen, T Bains, S Murray, R Knight, K Shoop, J Bubalo, C Fowler, S Slater and R T Maziarz Bone Marrow Transplant 2012 47: 1526-1529; advance online publication, May 7, 2012; 10.1038/bmt.2012.74 Abstract | Full Text PEDIATRIC TRANSPLANTS Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing’s sarcoma K Drabko, A Raciborska, K Bilska, J Styczynski, M Ussowicz, M Choma, B Wojcik, A Zaucha-Prazmo, E Gorczynska, S Skoczen, W Wozniak, A Chybicka, M Wysocki, J Gozdzik and J Kowalczyk Bone Marrow Transplant 2012 47: 1530-1534; advance online publication, May 21, 2012; 10.1038/bmt.2012.78 Abstract | Full Text ALLOGRAFTING Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers S M Sengsayadeth, M Jagasia, B G Engelhardt, A Kassim, S A Strickland, S Goodman, C Lucid, C L Vnencak-Jones, J P Greer and B N Savani Bone Marrow Transplant 2012 47: 1535-1537; advance online publication, June 4, 2012; 10.1038/bmt.2012.88 Abstract | Full Text Evaluation of BM cytomorphology after allo-SCT in patients with AML M Christopeit, K Miersch, E Klyuchnikov, T Haferlach, M Binder, T Zabelina, F Ayuk, P Schafhausen, A R Zander, C Bokemeyer, N Kröger and U Bacher Bone Marrow Transplant 2012 47: 1538-1544; advance online publication, April 30, 2012; 10.1038/bmt.2012.70 Abstract | Full Text POST-TRANSPLANT EVENTS Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma H F Dean, A Cazaly, C Hurlock, J Borras, A P Williams, P W Johnson and A J Davies Bone Marrow Transplant 2012 47: 1545-1551; advance online publication, May 14, 2012; 10.1038/bmt.2012.73 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation Y Fløisand, L Brinch, T Gedde-Dahl, G E Tjønnfjord, I Dybedal, H Holte, D Heldal, D Torfoss, E Aurlien, G F Lauritzsen, A Fosså, G Lehne, E Baggerød, G Kvalheim, T Egeland, M R Bishop, D H Fowler and A Kolstad Bone Marrow Transplant 2012 47: 1552-1557; advance online publication, April 23, 2012; 10.1038/bmt.2012.63 Abstract | Full Text Autologous platelet lysate for treatment of refractory ocular GVHD S Pezzotta, C Del Fante, L Scudeller, M Cervio, E R Antoniazzi and C Perotti Bone Marrow Transplant 2012 47: 1558-1563; advance online publication, April 23, 2012; 10.1038/bmt.2012.64 Abstract | Full Text Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation N Dhédin, T Prébet, R Peffault De Latour, S Katsahian, M Kuentz, N Piard, D Réa, F Norol, J P Jouet, J A Ribeil, R Tabrizi, B Rio, B Lioure, P Tiberghien, J H Bourhis, A Sirvent, P Bordigoni, D Blaise, M Michallet and J P Vernant for the Société Française de Greffe de Moelle et de Thérapie Cellulaire Bone Marrow Transplant 2012 47: 1564-1568; advance online publication, May 21, 2012; 10.1038/bmt.2012.75 Abstract | Full Text PRE-CLINICAL STUDIES Irradiated allogeneic cells enhance umbilical cord blood stem cell engraftment in immunodeficient mice T Budak-Alpdogan, G Jeganathan, K-C Lee, Z R Mrowiec, D J Medina, D Todd, D Moore, J R Bertino and R Strair Bone Marrow Transplant 2012 47: 1569-1576; advance online publication, May 21, 2012; 10.1038/bmt.2012.69 Abstract | Full Text QUALITY OF LIFE Comparison of early quality of life outcomes in autologous and allogeneic transplant patients C M Garcia, P B Mumby, S Thilges and P J Stiff Bone Marrow Transplant 2012 47: 1577-1582; advance online publication, May 7, 2012; 10.1038/bmt.2012.77 Abstract | Full Text Letters to the Editor Top Chimerism analyses by sex-chromosome analysis confused relapse with donor cell leukemia after sex-mismatched allo-SCT T Matsukawa, A Shigematsu, K Hayasaka, S Fujisawa, S Asanuma, A Yasumoto, H Goto, M Takahata, T Endo, J Tanaka, S Hashino, C Shimizu and M Imamura Bone Marrow Transplant 2012 47: 1583-1584; advance online publication, April 9, 2012; 10.1038/bmt.2012.61 Full Text Complete resolution of guttate psoriasis following autologous SCT for Ewing’s sarcoma in a pediatric patient K Held, R Rahmetulla, T W Loew and M A Radhi Bone Marrow Transplant 2012 47: 1585-1586; advance online publication, April 23, 2012; 10.1038/bmt.2012.68 Full Text Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor N Shimizu, E Sakaida, C Ohwada, M Takeuchi, T Kawaguchi, S Tsukamoto, S Sakai, Y Takeda, Y Sugita, K Yokote, T Iseki, S Isose, K Kanai, S Misawa, S Kuwabara and C Nakaseko Bone Marrow Transplant 2012 47: 1587-1588; advance online publication, May 21, 2012; 10.1038/bmt.2012.80 Full Text Advertisement Submit your research to BMT today * Hassle-free submission * Efficient peer-review * Articles published weekly online ahead of print * Open access option * High visibility via nature.com * Inclusion in the leading abstracting and indexing services For the full Guide to Authors visit www.nature.com/bmt   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.